NCT05249569 2023-05-03Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular CarcinomaUniversity of Texas Southwestern Medical CenterPhase 2 Terminated1 enrolled 4 charts
NCT03289533 2020-09-04A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)PfizerPhase 1 Completed22 enrolled 25 charts